Epidemiological study of pancreatic diabetes in japan in 2005: A nationwide study

Pancreas

Volumn 39, Issue 6, 2010, Pages 829-835

  Ito, Tetsuhide ^a   Otsuki, Makoto ^b   Igarashi, Hisato ^a   Kihara, Yasuyuki ^b   Kawabe, Ken ^a   Nakamura, Taichi ^a   Fujimori, Nao ^a   Oono, Takamasa ^a   Takayanagi, Ryoichi ^a   Shimosegawa, Tooru ^c  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

chronic pancreatitis; diabetic complication; epidemiology; nationwide survey; pancreatic diabetes

Indexed keywords

INSULIN;

ALCOHOLIC PANCREATITIS; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHRONIC PANCREATITIS; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DRINKING BEHAVIOR; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; JAPAN; LIFESTYLE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS DISEASE; PANCREATIC DIABETES; PRIORITY JOURNAL;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; HUMANS; HYPOGLYCEMIA; INCIDENCE; JAPAN; PANCREATIC DISEASES; PANCREATITIS, ALCOHOLIC; PREVALENCE; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 77955178106     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181ca3da4     Document Type: Article

References (32)

1. Owyang C. Endocrine changes in pancreatic insufficiency. In: Go VLW, DiMagno EP, eds. The Pancreas: Biology, Pathobiology and Disease. New York, NY: Raven; 1993:8803-8813.
2. Angelopoulos N, Dervenis C, Goula A, et al. Endocrine pancreatic insufficiency in chronic pancreatitis. Pancreatology. 2005;5:122-131.
3. Kawabe K, Ito T, Igarashi H, et al. The current managements of pancreatic diabetes in Japan. Clin J Gastroenterol. 2009;2:1-8.
4. Czakó L, Hegyi P, Rakonczay Z, et al. Interactions between the endocrine and exocrine pancreas and their clinical relevance. Pancreatology. 2009;9:351-359.
5. Okuno G, Oki A, Kawakami F, et al. Prevalence and clinical features of diabetes mellitus secondary to chronic pancreatitis in Japan: a study by questionnaire. Diabetes Res Clin Pract. 1990;10:65-71.
6. Koizumi M, Yoshida Y, Abe N, et al. Pancreatic diabetes in Japan. Pancreas. 1998;16:385-391.
7. Kuzuya T, Iwamoto Y, Kobayashi M, et al. Report of the committee on the classification and diagnosis criteria of diabetes mellitus. Diabetes Res Clin Pract. 2002;55:65-85.
8. Wellmann KF, Volk BW. Nodular intercapillary glomeruloscrelosis in diabetes secondary to chronic calcific pancreatitis. Diabetes. 1976; 25:713-716.
9. King SE. The syndrome of chronic relapsing pancreatitis, the frequency of insular deficiency (pancreatic diabetes) in the fibrocalcific stage. Med Clin North Am. 1949;33:883-897.
10. Ohno Y. The Nationwide Epidemiological Survey Manual for Investigating the Number of Patients and Clinico-Epidemiological Features of Intractable Diseases [in Japanese]. Tokyo, Japan: Japanese Ministry of Health and Welfare; 1998.
11. Verdonk C, Palumbo P, Gharib H, et al. Diabetic microangiopathy in patients with pancreatic diabetes mellitus. Diabetologia. 1975;11: 395-400.
12. Couet C, Genton P, Pointel J, et al. The prevalence of retinopathy is similar in diabetes mellitus secondary to chronic pancreatitis with or without pancreatectomy and in idiopathic diabetes mellitus. Diabetes Care. 1985;8:323-328.
13. Briani G, Riva F, Midena E, et al. Prevalence of microangiopathic complications in hyperglycemia secondary to pancreatic diabetes. J Diabetic Complications. 1988;2:50-52.
14. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2007;30:S42-S47.
15. Davies M, Brophy S, Williams R, et al. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006;29:1518-1522.
16. Kalk WJ, Vinik AI, Jackson WP, et al. Insulin secretion and pancreatic exocrine function in patients with chronic pancreatitis. Diabetologia. 1979;16:355-358.
17. Bank S, Marks IN, Vinik AI. Clinical and hormonal aspects of pancreatic diabetes. Am J Gastroenterol. 1975;64:13-22.
18. Malka D, Hammel P, Sauvanet A, et al. Risk factors for diabetes mellitus in chronic pancreatitis. Gastroenterology. 2000;119:1324-1332.
19. Ito T, Otsuki M, Itoi T, et al. Pancreatic diabetes in a follow-up survey of chronic pancreatitis in Japan. J Gastroenterol. 2007;42:291-297.
20. Owens DR, Jones IR, Birtwell AJ, et al. Study of porcine and human isophane (NPH) insulins in normal subjects. Diabetologia. 1984;26: 261-265.
21. Peters A, Klose O, Hefty R, et al. The influence of insulin antibodies on the pharmacokinetics of NPH insulin in patients with type 1 diabetes treated with human insulin. Diabet Med. 1995;12:925-930.
22. Pieber TR, Eugene-Jolchine I, Derobert E. The European Study Group of HOE 901 in Type1 Diabetes. Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. Diabetes Care. 2000;23:157-162.
23. Ratner RE, Hirsch IB, Neifing JL, et al. The U.S. Study Group of Insulin Glargine in Type 1 Diabetes. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. Diabetes Care. 2000;23:639-643.
24. Riddle MC, Rosenstock J, Gerich J. The Insulin Glargine 4002 Study Investigators. Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care. 2003;26:3080-3086.
25. Yki-Jarvinen H, Dressler A, Ziemen M. The HOE 901/3002 Study Group. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. Diabetes Care. 2000;23:1130-1136.
26. Porcellati F, Rossetti P, Busciantella NR, et al. Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes. A double-blind randomized, crossover study. Diabetes Care. 2007;30:2447-2452.
27. Otsuki M. Chronic pancreatitis in Japan: epidemiology, prognosis, diagnostic criteria, and future problems. J Gastroenterol. 2003; 38:315-326.
28. Otsuki M. Chronic pancreatitis. The problems of diagnostic criteria. Pancreatology. 2004;4:28-41.
29. Hegyi P, Takacs T, Jarmay K, et al. Spontaneous and cholecystokinin- octapeptideYpromoted regeneration of the pancreas following L-arginineYinduced pancreatitis in rat. Int J Pancreatol. 1997;22:193-200.
30. Takacs T, Hegyi P, Jarmai K, et al. CCK fails to promote pancreatic regeneration in diabetic rats following the induction of experimental pancreatitis. Pharm Res. 2001;44:363-372.
31. Hegyi P, Takacs T, Tiszlavicz L, et al. Recovery of exocrine pancreas six months following pancreatitis induction with L-arginine in streptozotocin- diabetic rats. J Physiol Paris. 2000;94:51-55.
32. Balk MW, Lang CM, White WJ, et al. Exocrine pancreatic dysfunction in guinea pigs with diabetes mellitus. Lab Invest. 1975;32:28-32.